Afghanistan vs Nicaragua: HIV-positive TB patients on ART (antiretroviral therapy)
Afghanistan
100.0%
in 2024
Nicaragua
100.0%
in 2023
Afghanistan rank
1st
Nicaragua rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Afghanistan
- Nicaragua
How they compare
Afghanistan currently reports 100.0% against 100.0% in Nicaragua, a difference of 0.0%.
The two have swapped places 7 times across 13 shared years of data; in 2009 it was Afghanistan ahead.
Afghanistan ranks 1st and Nicaragua ranks 1st of 144 countries.
Across the 3 decades both report, Afghanistan averaged higher in 2 and Nicaragua in 1.
Head to head by decade
| Decade | Afghanistan | Nicaragua | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 100.0% | 94.0% | 6.0% | Afghanistan |
| 2010s | 78.8% | 87.4% | 8.6% | Nicaragua |
| 2020s | 100.0% | 98.2% | 1.8% | Afghanistan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Afghanistan or Nicaragua?
- Afghanistan, at 100.0% against 100.0% in Nicaragua as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Afghanistan and Nicaragua?
- 0.0%, with Afghanistan ahead.
- How many years of comparable data are there for Afghanistan and Nicaragua?
- 13 years are reported by both, from 2009 to 2023.
- How do Afghanistan and Nicaragua rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Afghanistan ranks 1st and Nicaragua ranks 1st of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.